课题基金 / 基金详情

REGULATION OF INNATE IMMUNITY TO ENTEROCYTOZOON BIENEUSI INFECTION

REGULATION OF INNATE IMMUNITY TO ENTEROCYTOZOON BIENEUSI INFECTION
对肠细胞虫感染的先天免疫的调节
批准号:
7958373
负责人:
SAUL r TZIPORI
金额:
$11.19万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2010-04-30

项目摘要

项目成果

SAUL r TZIPORI的其他基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 从感染SIV的动物身上收集粪便,分析是否存在EB孢子,并从其中提纯EB孢子用于实验室研究:1)人和恒河猴比氏肠胞殖子的比较:异同;2)体外或体内对纯化的EB孢子的天然免疫反应的特征。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The feces were collected from SIV-infected animals and were analyzed for the presence of Eb spores from which they were purified for laboratory investigations: 1) Comparison of Enterocytozoon bieneusi from Human and Rhesus macaque: Similarities and Differences; 2) Characterization of the innate immune responses in vitro or in vivo to the purified Eb spores.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Aptamer-Based Therapy Against HUS
  • 批准号:
    7644745
  • 项目类别:
  • 资助金额:
    $68.11万
  • 财政年份:
    2009
  • 负责人:
    SAUL r TZIPORI
  • 依托单位:
Development of Aptamer-Based Therapy Against HUS
  • 批准号:
    7929518
  • 项目类别:
  • 资助金额:
    $66.47万
  • 财政年份:
    2009
  • 负责人:
    SAUL r TZIPORI
  • 依托单位:
INNATE IMMUNITY OF ENTEROCYTOZOON BIENEUSI (EB) IN VIVO
  • 批准号:
    7715540
  • 项目类别:
  • 资助金额:
    $5.52万
  • 财政年份:
    2008
  • 负责人:
    SAUL r TZIPORI
  • 依托单位:
CONTRIBUTION OF OIS TO INTESTINAL DYSFUNCTION AND WASTING
  • 批准号:
    7562006
  • 项目类别:
  • 资助金额:
    $10.36万
  • 财政年份:
    2007
  • 负责人:
    SAUL r TZIPORI
  • 依托单位: